Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica J Friton

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Inflammatory Bowel Diseases|December 1, 2023
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic PouchitisPriscila Santiago, Kevin P Quinn, Jun Chen, et al.
Diseases of the Colon and Rectum|December 20, 2022
Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug TrialEric J Dozois, Amy L Lightner, Allan B Dietz, et al.
Inflammatory Bowel Diseases|March 16, 2021
Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease PatientsMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Diseases of the Colon and Rectum|January 22, 2019
Early Results of a Phase I Trial Using an Adipose-Derived Mesenchymal Stem Cell-Coated Fistula Plug for the Treatment of Transsphincteric Cryptoglandular FistulasEric J Dozois, Amy L Lightner, Kellie L Mathis, et al.
BMJ Open Gastroenterology|October 13, 2023
Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel diseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Journal of Crohn'S & Colitis|January 29, 2019
Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel DiseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|October 19, 2019
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US ExperienceMing-Hsi Wang, Omar Y Mousa, Jessica J Friton, et al.
Clinical and Translational Gastroenterology|July 13, 2023
Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative ColitisMing-Hsi Wang, Jessica J Friton, Nancy Rebert, et al.
Cell Death and Differentiation|June 5, 2021
RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel diseaseRobyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat, et al.
The Journal of Biological Chemistry|December 3, 2016
The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)Olga F Sarmento, Phyllis A Svingen, Yuning Xiong, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Inflammatory Bowel Diseases|December 1, 2023
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic PouchitisPriscila Santiago, Kevin P Quinn, Jun Chen, et al.
Diseases of the Colon and Rectum|December 20, 2022
Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug TrialEric J Dozois, Amy L Lightner, Allan B Dietz, et al.
Inflammatory Bowel Diseases|March 16, 2021
Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease PatientsMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Diseases of the Colon and Rectum|January 22, 2019
Early Results of a Phase I Trial Using an Adipose-Derived Mesenchymal Stem Cell-Coated Fistula Plug for the Treatment of Transsphincteric Cryptoglandular FistulasEric J Dozois, Amy L Lightner, Kellie L Mathis, et al.
BMJ Open Gastroenterology|October 13, 2023
Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel diseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Journal of Crohn'S & Colitis|January 29, 2019
Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel DiseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|October 19, 2019
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US ExperienceMing-Hsi Wang, Omar Y Mousa, Jessica J Friton, et al.
Clinical and Translational Gastroenterology|July 13, 2023
Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative ColitisMing-Hsi Wang, Jessica J Friton, Nancy Rebert, et al.
Cell Death and Differentiation|June 5, 2021
RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel diseaseRobyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat, et al.
The Journal of Biological Chemistry|December 3, 2016
The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)Olga F Sarmento, Phyllis A Svingen, Yuning Xiong, et al.
Pageof 1